Evaluating conflict-of-interest governance among Canadian medical societies using a novel assessment tool: A cross-sectional study
Authors:
Open Access
- 14 May 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0348311
Abstract
Background: Medical societies shape clinical standards, develop practice guidelines, and provide continuing education to physicians. Many receive funding from pharmaceutical and medical device companies, creating conflicts of interest (COI); however, organizational-level COI governance in medical societies remains largely unexamined. We developed what is, to our knowledge, the first comprehensive tool to assess medical society COI policies and applied it to Canadian medical societies. Methods and findings: We identified 68 Canadian medical societies meeting our inclusion criteria and systematically searched the publicly accessible sections of their websites for COI policies. Two researchers independently analyzed policies using our 51-item tool covering nine domains: continuing medical education/continuing professional development (CME/CPD), leadership COI, clinical practice guidelines, industry relationships, research funding, external funding, annual general meetings, staff COI, and society journals. Only 33 societies (48.5%) had any publicly available COI policy, and those with policies addressed an average of only 1.85 domains (20.5% of possible domain coverage). The most frequently addressed domain was CME/CPD (22 societies, 32.4%), followed by leadership COI (12 societies, 17.6%). Within domains where policies existed, societies covered an average of only 32.5% of relevant items. The most common policy item was speakers’ declaration of COI in CME/CPD activities (16 societies, 23.5%). Policies addressing research funding, external funding, annual meetings, and staff COI were rare (1.5–5.9% of societies). Where present, policies were generally restrictive but narrow in scope. Conclusions: Most Canadian medical societies lack comprehensive COI governance, and existing policies are fragmented and reactive. More transparent, comprehensive, and enforceable frameworks are needed to protect institutional independence and public trust. The assessment tool may be adaptable for use in other jurisdictions to support international standardization and best-practice development.Keywords
Funding Information
- Economic and Social Research Council (UKRI2500)
This publication has 24 references indexed in Scilit:
- Financial Relationships Between Pharmaceutical Companies and Internal Medicine SocietiesJAMA Network Open, 2024
- Sponsorship of Canadian Professional Medical Societies by Drug, Medical Device and Medical Technology Companies: a Cross-sectional StudyJournal of General Internal Medicine, 2022
- Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic ReviewMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021
- Financial Conflicts of Interest and the Centers for Disease Control and Prevention’s 2016 Guideline for Prescribing Opioids for Chronic PainJAMA Internal Medicine, 2017
- Proliferation of gynaecological scientific societies and their financial transparency: an Italian surveyBMJ Open, 2016
- Conflict of interest and professional medical associations: the North American Spine Society experienceThe Spine Journal, 2013
- Generic Immunosuppression in Solid Organ TransplantationTransplantation, 2012
- Professional Medical Associations and Their Relationships With IndustryJAMA, 2009
- Cooperative partnerships or conflict‐of‐interest? A national survey of interaction between the pharmaceutical industry and medical organizationsInternal Medicine Journal, 2005
- Medical journals and pharmaceutical companies: uneasy bedfellowsBMJ, 2003